The Critical Role of 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile in Bosutinib Synthesis
In the complex landscape of pharmaceutical manufacturing, the availability of high-purity intermediates is paramount. One such critical compound is 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile, a vital building block in the synthesis of Bosutinib. This article delves into the significance of this intermediate and the importance of sourcing it from reputable manufacturers and suppliers, particularly those based in China.
Bosutinib is a tyrosine kinase inhibitor used to treat certain types of chronic myeloid leukemia (CML). The efficacy and safety of this life-saving medication are directly linked to the quality of its constituent components, starting from the very initial intermediates. 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile, identified by its CAS number 214470-66-3, serves as a foundational element in the multi-step chemical processes required to produce Bosutinib. Its specific molecular structure and chemical properties are meticulously engineered to facilitate the subsequent reactions, ensuring the final API meets stringent pharmaceutical standards.
As a manufacturer in China, NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of supplying intermediates with exceptional purity and consistency. The production of 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile requires advanced chemical synthesis techniques, careful process control, and rigorous quality assurance measures. Companies seeking to purchase this intermediate often look for suppliers who can guarantee a reliable supply chain, competitive pricing, and adherence to international quality benchmarks. The ability to buy this chemical intermediate with confidence is essential for uninterrupted production lines and the timely delivery of pharmaceuticals to patients.
The physical characteristics of 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile, typically appearing as a light yellow to yellow powder with an assay of ≥98.0%, further underscore its suitability for pharmaceutical applications. Proper storage, usually in a cool, ventilated place, is crucial to maintain its stability and prevent degradation. For businesses involved in Bosutinib API production, partnering with a trusted supplier in China like NINGBO INNO PHARMCHEM CO.,LTD. ensures they receive a product that meets all necessary specifications. This not only optimizes their manufacturing processes but also contributes to the overall quality of the final drug product.
The global demand for effective cancer treatments continues to grow, making intermediates like 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile indispensable. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical industry by providing this essential chemical. We aim to be your preferred supplier for Bosutinib intermediate needs, offering competitive prices and unparalleled quality. Whether you are looking to purchase this compound for research, development, or large-scale manufacturing, our team is ready to assist you. For inquiries or to obtain a quotation, please reach out to us.
Perspectives & Insights
Molecule Vision 7
“Bosutinib is a tyrosine kinase inhibitor used to treat certain types of chronic myeloid leukemia (CML).”
Alpha Origin 24
“The efficacy and safety of this life-saving medication are directly linked to the quality of its constituent components, starting from the very initial intermediates.”
Future Analyst X
“7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile, identified by its CAS number 214470-66-3, serves as a foundational element in the multi-step chemical processes required to produce Bosutinib.”